Basics GRAIL, Inc. Common Stock IPO Date: June 25, 2024 Sector: Healthcare Industry: Diagnostics and Research Market Cap: $1.33B Activated in VL: True Average Daily Range Avg Daily Range: $1.25 | 4.53% Avg Daily Range (30 D): $0.92 | 2.66% Avg Daily Range (90 D): $1.40 | 3.70% Institutional Daily Volume Avg Daily Volume: 1.1M Avg Daily Volume (30 D): .7M Avg Daily Volume (90 D): 1.08M Trade Size Avg Trade Size (Sh.): 74 Avg Trade Size (Sh.) (30 D): 52 Avg Trade Size (Sh.) (90 D): 60 Institutional Trades Total Inst.Trades: 507 Avg Inst. Trade: $2.2M Avg Inst. Trade (30 D): $2.18M Avg Inst. Trade (90 D): $2.81M Avg Inst. Trade Volume: .08M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $2.84M Avg Closing Trade (30 D): $2.44M Avg Closing Trade (90 D): $4.14M Avg Closing Volume: 100.04K     News Jul 25, 2025 @ 8:55 AM Minimal Residual Disease Testing Market Trends Ana... Source: Researchandmarkets.Com Apr 22, 2025 @ 4:09 PM Quest Diagnostics Revenue Rebound, Strategic Moves... Source: Vandana Singh Mar 28, 2025 @ 12:37 PM Jim Cramer: Healthpeak Properties Is A 'Reasonable... Source: Avi Kapoor Feb 19, 2025 @ 3:06 PM Investors Eye Biotech Sector as Cancer Therapy Mar... Source: Prnewswire Sep 3, 2024 @ 1:48 PM European Court Rules In Favor Of Illumina In Fight... Source: Vandana Singh Financials   TTM Q1 2025 Q4 2024 Basic EPS $-60.03 $-3.1 $-1.93 Diluted EPS $-60.03 $-3.1 $-1.93 Revenue $ 130.71M $ 31.84M $ 38.25M Gross Profit $ $ $ Net Income / Loss $ -1914.3M $ -106.21M $ -97.07M Operating Income / Loss $ -2115.34M $ -153.61M $ -136.94M Cost of Revenue $ $ $ Net Cash Flow $ 13.88M $ -.06M $ -639.89M PE Ratio